506 related articles for article (PubMed ID: 18802112)
1. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor.
Attur M; Al-Mussawir HE; Patel J; Kitay A; Dave M; Palmer G; Pillinger MH; Abramson SB
J Immunol; 2008 Oct; 181(7):5082-8. PubMed ID: 18802112
[TBL] [Abstract][Full Text] [Related]
2. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes.
Nishitani K; Ito H; Hiramitsu T; Tsutsumi R; Tanida S; Kitaori T; Yoshitomi H; Kobayashi M; Nakamura T
J Cell Biochem; 2010 Feb; 109(2):425-33. PubMed ID: 19998410
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis.
Li X; Ellman M; Muddasani P; Wang JH; Cs-Szabo G; van Wijnen AJ; Im HJ
Arthritis Rheum; 2009 Feb; 60(2):513-23. PubMed ID: 19180509
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.
Moreno-Rubio J; Herrero-Beaumont G; Tardio L; Alvarez-Soria MA; Largo R
Arthritis Rheum; 2010 Feb; 62(2):478-88. PubMed ID: 20112374
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cartilage degradation and suppression of PGE
Akhtar N; Khan NM; Ashruf OS; Haqqi TM
Nutrition; 2017 Jan; 33():1-13. PubMed ID: 27908544
[TBL] [Abstract][Full Text] [Related]
7. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation.
Fushimi K; Nakashima S; You F; Takigawa M; Shimizu K
J Cell Biochem; 2007 Feb; 100(3):783-93. PubMed ID: 17031853
[TBL] [Abstract][Full Text] [Related]
9. Standardized butanol fraction of WIN-34B suppresses cartilage destruction via inhibited production of matrix metalloproteinase and inflammatory mediator in osteoarthritis human cartilage explants culture and chondrocytes.
Huh JE; Seo BK; Baek YH; Lee S; Lee JD; Choi DY; Park DS
BMC Complement Altern Med; 2012 Dec; 12():256. PubMed ID: 23241445
[TBL] [Abstract][Full Text] [Related]
10. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
Kim JH; Huh JE; Baek YH; Lee JD; Choi DY; Park DS
J Ethnopharmacol; 2011 Mar; 134(2):234-42. PubMed ID: 21182922
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes.
Sato T; Konomi K; Fujii R; Aono H; Aratani S; Yagishita N; Araya N; Yudoh K; Beppu M; Yamano Y; Nishioka K; Nakajima T
Ann Rheum Dis; 2011 Jan; 70(1):221-6. PubMed ID: 20870807
[TBL] [Abstract][Full Text] [Related]
12. Glatiramer acetate (GA), the immunomodulatory drug, inhibits inflammatory mediators and collagen degradation in osteoarthritis (OA) cartilage.
Attur M; Millman JS; Dave MN; Al-Mussawir HE; Patel J; Palmer G; Abramson SB
Osteoarthritis Cartilage; 2011 Sep; 19(9):1158-64. PubMed ID: 21745583
[TBL] [Abstract][Full Text] [Related]
13. Blocking of the P2X7 receptor inhibits the activation of the MMP-13 and NF-κB pathways in the cartilage tissue of rats with osteoarthritis.
Hu H; Yang B; Li Y; Zhang S; Li Z
Int J Mol Med; 2016 Dec; 38(6):1922-1932. PubMed ID: 27748894
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13.
Attur M; Yang Q; Shimada K; Tachida Y; Nagase H; Mignatti P; Statman L; Palmer G; Kirsch T; Beier F; Abramson SB
FASEB J; 2015 Oct; 29(10):4107-21. PubMed ID: 26092928
[TBL] [Abstract][Full Text] [Related]
15. Effects of FGF-2 and FGF receptor antagonists on MMP enzymes, aggrecan, and type II collagen in primary human OA chondrocytes.
Nummenmaa E; Hämäläinen M; Moilanen T; Vuolteenaho K; Moilanen E
Scand J Rheumatol; 2015; 44(4):321-30. PubMed ID: 25743336
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes.
Park SJ; Cheon EJ; Kim HA
Osteoarthritis Cartilage; 2013 Jul; 21(7):981-9. PubMed ID: 23611898
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2.
Molloy ES; Morgan MP; Doherty GA; McDonnell B; O'Byrne J; Fitzgerald DJ; McCarthy GM
Ann Rheum Dis; 2008 Dec; 67(12):1773-9. PubMed ID: 18223264
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1beta in chondrocytes from mice lacking microsomal prostaglandin E synthase-1.
Gosset M; Pigenet A; Salvat C; Berenbaum F; Jacques C
J Immunol; 2010 Nov; 185(10):6244-52. PubMed ID: 20943996
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
20. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice.
Miyaura C; Inada M; Suzawa T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
J Biol Chem; 2000 Jun; 275(26):19819-23. PubMed ID: 10749873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
